̽��ֱ��

GSK/Cambridge Strategic Partnership aims to develop next wave of ‘game-changing’ medicines

23 November 2015

GSK, the ̽��ֱ�� of Cambridge and Cambridge ̽��ֱ�� Hospitals NHS Foundation Trust today announce their Strategic Partnership, with the long-term ambition to jointly deliver new medicine to patients in the next 5-10 years.

Cambridge researchers and pharma in innovative new consortium to develop and study early stage drugs

28 July 2015

An innovative new Consortium will act as a ‘match-making’ service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases.

A chest X-ray demonstrating severe COPD (cropped)

MRC, GSK and five leading UK universities collaborate to crack difficult disease areas

15 July 2015

Cambridge has been part of a successful £16 million bid to work with the MRC, GSK and four other UK universities in a unique open innovation research initiative aiming to improve scientists’ understanding of inflammatory diseases that present a serious burden to patients.

New NICE thresholds could miss up to 4,000 women per year at risk from diabetes in pregnancy

12 June 2015

̽��ֱ��new threshold for diabetes in pregnancy recently introduced by the UK’s National Institute for Health and Care Excellence (NICE) misses a significant number of women at risk of serious complications, a report published today in the journal Diabetologia shows.

A close up of a young woman snorting cocaine during the 1920s

Possible tool to help cocaine users kick the habit

06 October 2011

Medicines which increase levels of the brain chemical dopamine may hold the key to helping those addicted to cocaine and amphetamines kick the habit, researchers from the ̽��ֱ�� of Cambridge have found.

Abnormal brain structure linked to chronic cocaine abuse

21 June 2011

Research gives insight into why some people develop addiction.

̽��ֱ��

Articles about 'GlaxoSmithKline (GSK)'

GSK/Cambridge Strategic Partnership aims to develop next wave of ‘game-changing’ medicines

Cambridge researchers and pharma in innovative new consortium to develop and study early stage drugs

MRC, GSK and five leading UK universities collaborate to crack difficult disease areas

New NICE thresholds could miss up to 4,000 women per year at risk from diabetes in pregnancy

Possible tool to help cocaine users kick the habit

Abnormal brain structure linked to chronic cocaine abuse

Connect with us

Study at Cambridge

About the ̽��ֱ��

Research at Cambridge

Articles about 'GlaxoSmithKline (GSK)'

Pages